It is incredibly important as a healthcare system that we start treating obesity as a long-term condition and wrap care around people living with obesity, which may include diet, lifestyle, psychological support and, for some people, medication to help them manage and lower their weight. 1.Wharton S, Freitas P, Hjelmesth J, et al
Daily options include liraglutide (Victoza, Saxenda), while weekly injectable formulations include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and exenatide extended-release (Bydureon BCise)
Ali MU, Mancini GBJ, Fitzpatrick-Lewis D, et al
A post hoc analysis of the phase IIb trial showed that tirzepatide was associated with a reduction in the level of high-sensitivity ICAM-1, CRP, and YKL-40 after 26 weeks of treatment in a dose-dependent manner [83, 103]
157 These differences necessitate a re-examination of clinical experiences in adults for application to children
In an initial pilot study, we demonstrated the need for more comprehensive validation [2]
